List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 35 studies with search of: "Fosamprenavir"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 No longer available Fosamprenavir Expanded Access
Condition: HIV Infection
Interventions: Drug: fosamprenavir;   Drug: Telzir®
2 Active, not recruiting A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects
Condition: HIV Infection
Interventions: Drug: fosamprenavir (GW433908);   Drug: ritonavir
3 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Condition: HIV Infection
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
4 Recruiting 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: HIV Infection
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
5 Completed Fosamprenavir Versus Other Protease Inhibitors
Condition: HIV Infection
Intervention: Drug: fosamprenavir
6 Completed A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
Condition: HIV Infection
Interventions: Drug: Full Boosted Fosamprenavir;   Drug: Half-boosted Fosamprenavir
7 Recruiting Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
8 Terminated Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects
Condition: HIV-1
Interventions: Drug: fosamprenavir/ritonavir (700mg/100mg BID);   Drug: fosamprenavir/ritonavir (1400mg/100mg BID);   Drug: fosamprenavir/lopinavir/ritonavir (1400mg/533mg/100mg BID)
9 Completed Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.
Condition: Healthy Subjects
Intervention: Drug: fosamprenavir + ritonavir + methadone
10 Completed A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
Condition: HIV Infection
Interventions: Drug: ritonavir;   Drug: fosamprenavir
11 Completed HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Condition: HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
12 Completed Plasma Amprenavir In HIV-1-Infected Adult Subjects With Liver Function Impairment
Conditions: HIV Infection;   Hepatic Impairment
Interventions: Drug: Fosamprenavir;   Drug: Ritonavir
13 Completed VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-State.
Conditions: Telaprevir;   HIV;   Hepatitis C
Intervention: Drug: Telaprevir; Darunavir; Ritonavir; Fosamprenavir
14 Recruiting Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Condition: HIV Infection
Interventions: Drug: GW433908;   Drug: ritonavir
15 Completed Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
Condition: HIV Infections
Interventions: Drug: fosamprenavir;   Drug: COMBIVIR;   Drug: ritonavir;   Drug: TRIZIVIR
16 Active, not recruiting "The Once A Day Protease Inhibitor Regimens"
Conditions: HIV Infections;   Antiretroviral Therapy
Interventions: Drug: ritonavir-boosted atazanavir;   Drug: ritonavir-boosted fosamprenavir
17 Completed An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects
Condition: Healthy
Interventions: Drug: Raltegravir;   Drug: Fosamprenavir
18 Completed Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
Condition: HIV Infections
Interventions: Drug: Fosamprenavir;   Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: Tenofovir disoproxil fumarate
19 Active, not recruiting Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: GW433908
20 Completed Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
Condition: HIV Infection
Intervention: Drug: No intervention; Observational study

Previous Page Studies Shown (1-20) Next Page (21-35)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services